recombinant vaccine
Promising Multiple-Epitope Recombinant Vaccine against Foot-and-Mouth Disease Virus Type O in Swine
... multiple-epitope recombinant vaccine has numerous advantages as an alternative to traditional ...a recombinant protein can be developed by genetic engineering and does not involve the use of ...
7
Recombinant vaccine for canine parvovirus in dogs.
... Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using a conventional antisera and monoclonal antibodies.. Dog response to in[r] ...
6
Characterization of a Recombinant Newcastle Disease Virus Vaccine Strain
... first recombinant NDV was generated by reverse genetics, various types of chimeric recombinant NDV strains have been ...the recombinant NDV strains had been applied to vaccines to replace conven- ...
8
Construction of Mtb72F Plasmid as a DNA Vaccine Candidate for Mycobacterium tuberculosis
... Mtb72F consists of the C- and N-terminal open reading frames (ORFs) of Mtb32 (Rv0125) with the mtb39 gene (Rv1196) between them. The resulting recombinant vaccine, Mtb72F, provided greater protection ...
7
In Vitro Study of the Toxicity Effects of Bacillus anthracis Protective Antigen
... Anthrax is a common disease of humans and chattels which is caused by Bacillus anthracis infection. Humans are infected through the direct contact to sick chattels or their products such as kips, hairs, or wools, so, ...
6
A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model
... MV-derived vaccine candi- date, MV-Zika-sE, and a prototypic inactivated flavivirus vaccine preparation to protect against the teratogenic sequelae of ZIKV ...MV vaccine strain-like characteristics, ...
15
Construction and Identification of a Recombinant Plasmid Encoding Echinococcus granulosus Oncosphere Antigen (EG95)Abstract Background: Cystic echinococcosis (CE), as a zoonotic disease cause to health threat and economic losses. Despite implemented cont
... the vaccine issue (6). EG95 recombinant vaccine was developed in 1996 which induced high protection (96-98%) in sheep and vaccine trials carried out in Australia, Argentina and China have ...
8
Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy
... combinant vaccine during infancy will become unable to demonstrate an anamnestic response as they grow ...received recombinant vaccine at birth boosted compared with children who also received the ...
11
A study on seroconversion rate following hepatitis B vaccination in chronic kidney disease population with current immunization strategy.
... HBV vaccine in patients with chronic kidney ...adjuvanted vaccine compared to control group of standard HBV recombinant ...HBV vaccine in this high-risk ...
82
Replacement of the Ectodomains of the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Recombinant Parainfluenza Virus Type 3 (PIV3) with Their Counterparts from PIV2 Yields Attenuated PIV2 Vaccine Candidates
... virus vaccine candidates can be updated annually by replacement of the HA and NA genes of the attenuated donor virus with those of a new epidemic or pandemic ...virus vaccine candidate for Japanese ...
11
A Booster Dose for Hepatitis B Vaccine should be Recommended by EPI in Saudi Arabia at Adolescence and Young Adulthood
... the recombinant hepatitis B vaccine within the first 24 hours of life was issued ...the recombinant hepatitis B vaccine birth dose must be administered as soon as possible following birth, ...
8
Production of a Candidate Recombinant Protein Vaccine for Mannheimia haemolytica in Lettuce and Tobacco Chloroplasts
... Another factor affecting transgenic protein levels is translational efficiency. As with all organisms, chloroplasts display biases towards using certain codons over others. Codons that are less common tend to result in ...
123
Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG Glycoprotein Vaccine in Cotton Rats
... effective vaccine against respiratory syncytial virus (RSV), now in its fourth decade, has alternately focused on nonreplicating and replicating candidate vaccines (reviewed in reference ...first vaccine to ...
6
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh
... This research was supported by the ICDDR,B and by the Intramural Re- search Program of the National Institutes of Health, NIDDK, and extra- mural grants from the National Institutes of Health, including the Na- tional ...
9
Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review
... of vaccine‑associated lesions in healthy non‑ human primates does not rule out the potential for adverse events from V‑RG exposure in immunocompro‑ mised ...rabies vaccine‑bait product) baits had been ...of ...
26
Click here to download PDF version of the article !
... Ebola virus disease (EVD) described as “one of the world’s most virulent diseases” by WHO was popularly known as Ebola haemorrhagic fever in the past. It is usually considered a severe and deadly illness when humans are ...
8
DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults
... plasmid-vectored vaccine (EP-1233) and (ii) a modified vaccinia virus Ankara (MVA-mBN32)-vectored ...HIV Vaccine Trials Units (HVTU) in the United ...
10
Mucosal vaccine delivery by non-recombinant spores of Bacillus subtilis
... We review here the use of non-recombinant spores of Bacillus subtilis as a delivery system for mucosal immuni- zations. Spores of B. subtilis are extremely resistant and stable, easy to manipulate and are known to ...
9
Cross-protection of mice against a global spectrum of rabies virus variants.
... or recombinant viruses expressing either the glycoprotein (TT-G), the nucleoprotein (VAC-N), or both the G and N (TT-GN) of the challenge virus standard (CVS) strain of rabies ...single vaccine virus strain ...
6
Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
... PV vaccine strains have been greatly facilitated now that the sequences of attenuated and virulent strain genomes are known (reviewed in references 31 and ...
9